Stock Events

Stock Events

Aptevo Therapeutics (APVO) Q2 2025 Earnings

15MayConfirmed

Q3 2024

Q4 2024

Q1 2025

Q2 2025

-87.8

-59.09

-30.38

-1.67

Details

Expected EPS

-84.2

Actual EPS

-87.8

Surprise EPS

-3.6

Surprise Percent

+4.28%

Description

Aptevo Therapeutics (APVO) has reported earnings of -87.8 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.